NTRK2 and amyotrophic lateral sclerosis: This review focuses on BDNF/TrkB signaling at the neuromuscular system, its alteration in ALS and on therapeutic approaches designed to preserve NMJs maintain motor function to preserve lower MNs and increase the life quality of patients.